Search

Your search keyword '"Ramakrishna, Bharat"' showing total 16 results
Start Over Author "Ramakrishna, Bharat"
16 results on '"Ramakrishna, Bharat"'

2. Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study

Author

Olesen, Scott W., Ramakrishna, Bharat, Dubois, Nancy, O’Brien, Kelsey, Fischer, Monika, Stollman, Neil, Hays, R. Ann, Kelly, Ciarán P., Amaratunga, Kanchana, Qazi, Taha, Crothers, Jessica W., Abend, Audrey, Bougas, Michael, Burns, Laura, Decaille-Hodge, Imani, Dickens, Michael, Edelstein, Carolyn, Gabdrakhmanova, Dinara, Kerwin, Clara, Landry, Richard, Ling, Kelly, Martin, Daniel, Medina, Geraldine, Mendolia, Gina, Muñoz, Rodrigo, Rao, Sanjay, Seng, Monica, Smith, Mark, Stehler, Laura, Yoder, Karl, Zellmer, Caroline, Osman, Majdi, Budree, Shrish, Kelly, Colleen R., Panchal, Pratik, Allegretti, Jessica R., and Kassam, Zain

Published
2022
Full Text
View/download PDF

4. Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study

Author

Osman, Majdi, primary, Budree, Shrish, additional, Kelly, Colleen R., additional, Panchal, Pratik, additional, Allegretti, Jessica R., additional, Kassam, Zain, additional, Olesen, Scott W., additional, Ramakrishna, Bharat, additional, Dubois, Nancy, additional, O’Brien, Kelsey, additional, Fischer, Monika, additional, Stollman, Neil, additional, Hays, R. Ann, additional, Kelly, Ciarán P., additional, Amaratunga, Kanchana, additional, Qazi, Taha, additional, Crothers, Jessica W., additional, Abend, Audrey, additional, Bougas, Michael, additional, Burns, Laura, additional, Decaille-Hodge, Imani, additional, Dickens, Michael, additional, Edelstein, Carolyn, additional, Gabdrakhmanova, Dinara, additional, Kerwin, Clara, additional, Landry, Richard, additional, Ling, Kelly, additional, Martin, Daniel, additional, Medina, Geraldine, additional, Mendolia, Gina, additional, Muñoz, Rodrigo, additional, Rao, Sanjay, additional, Seng, Monica, additional, Smith, Mark, additional, Stehler, Laura, additional, Yoder, Karl, additional, and Zellmer, Caroline, additional

Published
2022
Full Text
View/download PDF

5. Modeling Donor Screening Strategies to Reduce the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission via Fecal Microbiota Transplantation

Author

Olesen, Scott W, Zaman, Amanda, Osman, Majdi, and Ramakrishna, Bharat

Subjects
2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Clostridioides difficile, SARS-CoV-2, Transmission (medicine), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), fecal microbiota transplantation, Fecal bacteriotherapy, Virology, 03 medical and health sciences, AcademicSubjects/MED00290, fluids and secretions, 0302 clinical medicine, Infectious Diseases, Oncology, Medicine, Brief Reports, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business, Donor screening
Abstract

The potential for transmission of severe acute respiratory syndrome coronavirus 2 shed in stool via fecal microbiota transplantation is not yet known, and the effectiveness of various testing strategies to prevent fecal microbiota transplantation-based transmission has also not yet been quantified. In this study, we use a mathematical model to simulate the utility of different testing strategies., Using a mathematical model, we simulate the utility of different testing strategies to prevent the transmission of severe acute respiratory syndrome coronavirus 2 shed in stool via fecal microbiota transplantation.

Published
2020
Full Text
View/download PDF

11. Donor Screening for Fecal Microbiota Transplantation

Author

Kassam, Zain, primary, Dubois, Nancy, additional, Ramakrishna, Bharat, additional, Ling, Kelly, additional, Qazi, Taha, additional, Smith, Mark, additional, Kelly, Colleen R., additional, Fischer, Monika, additional, Allegretti, Jessica R., additional, Budree, Shrish, additional, Panchal, Pratik, additional, Kelly, Ciarán P., additional, and Osman, Majdi, additional

Published
2019
Full Text
View/download PDF

13. Shiga Toxin–Producing Escherichia coli Transmission via Fecal Microbiota Transplant.

Author

Zellmer, Caroline, Sater, Mohamad R A, Huntley, Miriam H, Osman, Majdi, Olesen, Scott W, and Ramakrishna, Bharat

Subjects
CLOSTRIDIUM disease treatment, DIAGNOSIS of escherichia coli diseases, ESCHERICHIA coli transmission, ESCHERICHIA coli disease prevention, HOST-bacteria relationships, MEDICAL screening, FECAL microbiota transplantation, BACTERIAL toxins, ADVERSE health care events
Abstract

Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin–producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

14. Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia.

Author

Lee, Matthew S. L., Ramakrishna, Bharat, Moss, Alan C., Gold, Howard S., and Branch‐Elliman, Westyn

Subjects
*FECAL microbiota transplantation, *ACUTE myeloid leukemia, *INFECTION, *IMMUNOCOMPROMISED patients, *PSEUDOMONAS aeruginosa, *AGRANULOCYTOSIS
Abstract

We present a patient with acute myeloid leukemia and prolonged, severe neutropenia who developed fulminant Clostridioides difficile infection refractory to medical therapy and was high‐risk for surgical intervention. He was treated with fecal microbiota transplantation (FMT) for life‐saving cure. The patient had subsequent clinical improvement, however, developed multidrug‐resistant Pseudomonas aeruginosa bacteremia 2 days post‐procedure. We describe subsequent investigation of this event that found this bacteremia was not related to the donor stool administered during FMT. This case adds to the literature that FMT could be considered in heavily immunocompromised patients with fulminant Clostridioides difficile infection where maximal medical therapy has been ineffective and surgery may carry an excessively high mortality risk. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results